-
1
المؤلفون: Wanxin Wen, Jiahui Lin, Xiaojia Ni, Yaolong Chen, Lei Wu, Yuntao Liu, Lin Lin, Jianwen Guo, Yefeng Cai, Donghui Huang, Yidan Zhang, Xufei Luo
المصدر: Phytomedicine
مصطلحات موضوعية: CBM, China Biology Medicine, Pharmaceutical Science, Review, Disease, Cochrane Library, law.invention, RCT, randomized controlled trials, 0302 clinical medicine, Randomized controlled trial, law, NOS, Newcastle-Ottawa Scale, Drug Discovery, CHM, Chinese herbal medicine, Medicine, Medicine, Chinese Traditional, COVID-19, coronavirus disease 2019, 0303 health sciences, NHC PRC, National Health Commission of the People's Republic of China, PHEIC, Public Health Emergency of International Concern, OR, odds ratios, WMD, weighted mean differences, Combined Modality Therapy, CT, computed tomography, 030220 oncology & carcinogenesis, Meta-analysis, Molecular Medicine, Chinese herbal medicine, PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-analysis, RoB, Risk of Bias, Cohort study, medicine.medical_specialty, Coronavirus disease 2019 (COVID-19), Combination therapy, RT-PCR, reverse transcription-polymerase chain reaction, WHO, World Health Organization, 03 medical and health sciences, CNKI, China National Knowledge Infrastructure, Internal medicine, Humans, AE, adverse effects, Adverse effect, 030304 developmental biology, Pharmacology, business.industry, COVID-19, Length of Stay, COVID-19 Drug Treatment, Complementary and alternative medicine, CI, confidence intervals, Systematic review, business, Drugs, Chinese Herbal, GRADE, Grading of Recommendations Assessment, Development and Evaluation
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.
